Company
GlycoMar is a biotechnology company discovering and developing products for the healthcare and personal care markets.
The company, founed in 2005, has an established discovery platform technology based on marine natural products, which generates valuable intellectual property.
GlycoMar is developing novel pharmaceutical products for the treatement of inflammatory disorders such as psoriasis, asthma, and inflammatory bowel disease. The company is also developing cosmetic ingredients for the skincare market. Our development programme is being carried out both in house and with commecial partners.
GlycoMar seeks to develop its discoveries to generate value through out licensing. The value of GlycoMar's technology has been demosntarted through early stage Licensing and Collaboration deals.
For more information on the biotechnology industry visit biotechnologycompanies.net.